Comparison of second cancer risk due to out-of-field doses from 6-MV IMRT and proton therapy based on 6 pediatric patient treatment plans

Radiotherapy and Oncology

Volumn 98, Issue 1, 2011, Pages 87-92

  Athar, Basit S ^a   Paganetti, Harald ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

IMRT; Pediatric radiation oncology; Proton therapy; Second cancer risk; Whole body phantom

Indexed keywords

ARTICLE; BEAM THERAPY; BLADDER CANCER; CANCER RISK; COMPARATIVE STUDY; INTENSITY MODULATED RADIATION THERAPY; PEDIATRICS; PHANTOM; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE; RISK ASSESSMENT; SECOND CANCER; THYROID CANCER; TREATMENT PLANNING;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NEOPLASMS, SECOND PRIMARY; PROTONS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 78651378610     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.11.003     Document Type: Article

References (28)

1. C. Zacharatou Jarlskog Assessment of organ specific neutron doses in proton therapy using whole-body age-dependent voxel phantoms Phys Med Biol 53 2008 693 717 (Pubitemid 351496213)
2. S.B. Athar, and H. Paganetti Neutron equivalent doses and associated lifetime cancer incidence risks for head & neck and spinal proton therapy Phys Med Biol 54 2009 4026 4907
3. E.J. Hall Intensity-modulated radiation therapy, protons, and the risk of second cancers Int J Radiat Oncol Biol Phys 65 2006 1 7
4. BEIR VII, 2006. Biological Effects of Ionizing Radiation Committee. Health risks from exposure to low level of ionizing radiation, National Research Council, National Academy of Science. Report; 2006.
5. M. Bassal, A.C. Mertens, and Taylor Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the childhood cancer survivor study J Clin Oncol 24 2006 476 483 (Pubitemid 46630467)
6. J.P. Neglia, D.L. Friedman, and Y. Yasui Second malignant neoplasms in five-year survivors of childhood cancers: childhood cancer survivor study J Natl Cancer Inst 93 2001 618 629 (Pubitemid 32409629)
7. M. Tubiana Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review Radiother Oncol 91 2009 4 15
8. E.J. Hall, and C.S. Wuu Radiation-induced second cancers: the impact of 3D-CRT and IMRT Int J Radiat Oncol Biol Phys 56 2003 83 88
9. E.J. Hall, and H.S. Kaplan Distinguished Scientist Award 2003 the crooked shall be made straight; dose response relationships for carcinogenesis Int J Radiat Biol 80 2004 327 337
10. S.F. Kry The calculated risk of the fatal secondary malignancies from the intentsity-modulated radiation therapy Int J Radiat Oncol Biol Phys 62 2005 1105 1208
11. H. Paganetti, T. Bortfeld, and T.F. Delaney Neutron dose in proton radiation therapy: in regard to Eric J. Hall Int J Radiat Oncol Biol Phys 66 2006 1594 1595 [Int J Radiat Oncol Biol Phys 65: 1-7]
12. C. Zacharatou Jarlskog, and H. Paganetti Risk of developing second cancer from neutron dose in proton therapy as a function of field characteristics, organ and patient age Int J Radiat Oncol Biol Phys 72 2008 228 235
13. D.J. Brenner, and E.J. Hall Secondary neutrons in clinical proton radiotherapy: a charged issue Radiother Oncol 86 2008 165 170
14. W.D. Newhauser, J.D. Fontenot, A. Mahajan, and D. Kornguth The risk of developing a second cancer after receiving craniospinal proton irradiation Phys Med Biol 54 2009 2277 2291
15. P.J. Taddei, D. Mirkovic, J.D. Fontenot, A. Giebeler, and Y. Zheng Stray radiation dose and second patient receiving craniospinal irradiation with proton beam Phys Med Biol 54 2009 2259 2275
16. J.D. Fontenot, A.K. Lee, and W.D. Newhauser Risk of secondary malignant neoplams from proton therapy and intensit-modulated X-ray therapy for early-stage prostate cancer Int J Radiat Oncol Biol Phys 74 2009 616 622
17. V.C. Wilson, J. Mcdonough, and Z. Tochner Proton beam irradiation in pediatric oncology: an overview J Ped Hemat Oncol 27 2005 444 448 (Pubitemid 41233303)
18. S.F. Kry, M. Salepour, U. Titt, R.A. White, M. Stovall, and D. Followill Monte Carlo study shows no significant difference in second cancer risk between 6 and 18-MV intensity-modulated radiation therapy Radiother Oncol 91 2009 132 137
19. J. Medin, and P. Andrea Monte Carlo calculated stopping-power ratios, water/air, for clinical proton dosimetry (50-250 MeV) Phys Med Biol 42 1997 89 105 (Pubitemid 27055955)
20. S.B. Athar, B. Bednarz, J. Seco, C. Hancox, and H. Paganetti Comparison of out-of-field photon doses in 6-MV IMRT and neutron doses in proton therapy for adult and pediatric patients Phys Med Biol 55 2009 2879 2891
21. X.G. Xu, T.C. Chao, and A. Bozkurt VIP-MAN: an image-based whole-body adult male model constructed from color photographs of the Visible Human Project for multi-particle Monte Carlo calculations Health Phys 78 2000 476 485 (Pubitemid 30210781)
22. C. Lee, and W. Bolch Construction of a tomographic computational model of a 9 month-old and its Monte Carlo calculation time comparison between the MCNP4C and MCNPX codes Health Phys 84 2003 S259
23. C. Lee, J.L. Williams, C. Lee, and W.E. Bolch The UF series of tomographic computational phantoms of pediatric patients Med Phys 32 2005 3537 3548
24. R). International commission on radiological protection. Pergamon: Oxford; 2003. ICRP Publication 92.
25. R.N. Anderson, and P.B. DeTurk United states life tables Nat Vital Stat Rep 50 2002 1 12
26. SEER. Cancer statistics review 1975-2005. http://seer.cancer.gov/csr/ 1975-2005.
27. D.C. Kocher, A.I. Apostoei, and F.O. Hoffman Radiation effectiveness factors for use in calculating probability of causation of radiogenic cancers Health Phys 2005 3 32
28. ICRU, Prescribing, Recording, and Reporting Proton-Beam Therapy. J. ICRU Report 2007; 78.